Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 397

1.
2.
3.

Comparison of bone and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in the evaluation of bony metastases in lung cancer.

Gayed I, Vu T, Johnson M, Macapinlac H, Podoloff D.

Mol Imaging Biol. 2003 Jan-Feb;5(1):26-31.

PMID:
14499159
4.

Value of 18-fluorodeoxyglucose positron emission tomography in the management of patients with cystic tumors of the pancreas.

Sperti C, Pasquali C, Chierichetti F, Liessi G, Ferlin G, Pedrazzoli S.

Ann Surg. 2001 Nov;234(5):675-80.

5.

Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.

Chung JK, So Y, Lee JS, Choi CW, Lim SM, Lee DS, Hong SW, Youn YK, Lee MC, Cho BY.

J Nucl Med. 1999 Jun;40(6):986-92.

7.

Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography.

Meltzer CC, Luketich JD, Friedman D, Charron M, Strollo D, Meehan M, Urso GK, Dachille MA, Townsend DW.

Clin Nucl Med. 2000 Nov;25(11):882-7.

PMID:
11079584
8.

Staging and managing lung tumors using F-18 FDG coincidence detection.

Roman MR, Rossleigh MA, Angelides S, Walker BM, Dixon J.

Clin Nucl Med. 2001 May;26(5):383-8.

PMID:
11317014
9.

Mediastinal staging of non-small-cell lung cancer with positron emission tomography.

Chin R Jr, Ward R, Keyes JW, Choplin RH, Reed JC, Wallenhaupt S, Hudspeth AS, Haponik EF.

Am J Respir Crit Care Med. 1995 Dec;152(6 Pt 1):2090-6.

PMID:
8520780
10.

Comparison of fluorine-18-FDG PET and thallium-201 SPECT in evaluation of lung cancer.

Higashi K, Nishikawa T, Seki H, Oguchi M, Nambu Y, Ueda Y, Yuasa K, Tonami H, Okimura T, Yamamoto I.

J Nucl Med. 1998 Jan;39(1):9-15.

11.
12.

Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET).

Guhlmann A, Storck M, Kotzerke J, Moog F, Sunder-Plassmann L, Reske SN.

Thorax. 1997 May;52(5):438-41.

13.

Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET).

Duhaylongsod FG, Lowe VJ, Patz EF Jr, Vaughn AL, Coleman RE, Wolfe WG.

J Thorac Cardiovasc Surg. 1995 Jul;110(1):130-9; discussion 139-40.

14.

Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis.

Gould MK, Kuschner WG, Rydzak CE, Maclean CC, Demas AN, Shigemitsu H, Chan JK, Owens DK.

Ann Intern Med. 2003 Dec 2;139(11):879-92. Review.

PMID:
14644890
15.

Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.

Billé A, Pelosi E, Skanjeti A, Arena V, Errico L, Borasio P, Mancini M, Ardissone F.

Eur J Cardiothorac Surg. 2009 Sep;36(3):440-5. doi: 10.1016/j.ejcts.2009.04.003. Epub 2009 May 22. Review.

PMID:
19464906
16.

Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.

Avril N, Dose J, Jänicke F, Ziegler S, Römer W, Weber W, Herz M, Nathrath W, Graeff H, Schwaiger M.

J Natl Cancer Inst. 1996 Sep 4;88(17):1204-9.

PMID:
8780629
17.

Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma.

Yoon KT, Kim JK, Kim DY, Ahn SH, Lee JD, Yun M, Rha SY, Chon CY, Han KH.

Oncology. 2007;72 Suppl 1:104-10. Epub 2007 Dec 13.

PMID:
18087190
18.

Positron emission tomography in the evaluation of synchronous lung lesions in patients with untreated head and neck cancer.

Wax MK, Myers LL, Gabalski EC, Husain S, Gona JM, Nabi H.

Arch Otolaryngol Head Neck Surg. 2002 Jun;128(6):703-7.

PMID:
12049568
19.

Comparison of objective criteria and expert visual interpretation to classify benign and malignant hilar and mediastinal nodes on 18-F FDG PET/CT.

Nguyen P, Bhatt M, Bashirzadeh F, Hundloe J, Ware R, Fielding D, Ravi Kumar AS.

Respirology. 2015 Jan;20(1):129-37. doi: 10.1111/resp.12409. Epub 2014 Sep 28.

20.

Fluorodeoxyglucose positron emission tomography improves preoperative staging of resectable lung metastasis.

Pastorino U, Veronesi G, Landoni C, Leon M, Picchio M, Solli PG, Leo F, Spaggiari L, Pelosi G, Bellomi M, Fazio F.

J Thorac Cardiovasc Surg. 2003 Dec;126(6):1906-10.

Supplemental Content

Support Center